{
  "trial_id": "NCT01485614",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, Baseline Hemoglobin A1C (A1C), Ethnicity, Insulin Use, Baseline Fasting Plasma Glucose, Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Liver Function Tests (ALT, AST), Kidney Function Tests (Serum Creatinine, eGFR), History of Cardiovascular Disease, History of Hypertension, History of Liver Disease, History of Nephropathy, History of Neurological Disorders, History of Pancreatitis, History of Thyroid Disorders, History of Hematological Disorders, History of Drug or Alcohol Abuse, Concomitant Medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Glycated Hemoglobin (A1C)",
          "Baseline Hemoglobin A1C (A1C)"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity"
        ],
        [
          "Fasting Plasma Glucose",
          "Baseline Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index (BMI)",
        "Duration of Type 2 Diabetes Mellitus",
        "Insulin Use",
        "Blood Pressure",
        "Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides)",
        "Liver Function Tests (ALT, AST)",
        "Kidney Function Tests (Serum Creatinine, eGFR)",
        "History of Cardiovascular Disease",
        "History of Hypertension",
        "History of Liver Disease",
        "History of Nephropathy",
        "History of Neurological Disorders",
        "History of Pancreatitis",
        "History of Thyroid Disorders",
        "History of Hematological Disorders",
        "History of Drug or Alcohol Abuse",
        "Concomitant Medications"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Body Mass Index, Duration of Diabetes, Insulin Use, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycated Hemoglobin (A1C)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Insulin Use",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Insulin use, History of cardiovascular disease, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycated Hemoglobin (A1C)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Diabetes duration",
        "Insulin use",
        "History of cardiovascular disease",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, prior antihyperglycemic therapy, insulin use, A1C at screening, fasting plasma glucose at screening, systolic and diastolic blood pressure, heart rate, waist circumference, lipid profile, liver function tests, renal function tests, medical history (including cardiovascular disease, hypertension, and liver disease).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Glycated Hemoglobin (A1C)",
          "A1C at screening"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes mellitus",
        "prior antihyperglycemic therapy",
        "insulin use",
        "systolic and diastolic blood pressure",
        "heart rate",
        "waist circumference",
        "lipid profile",
        "liver function tests",
        "renal function tests",
        "medical history (including cardiovascular disease, hypertension, and liver disease)"
      ]
    }
  }
}